Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial (Q43130496)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2010
edit
Language Label Description Also known as
English
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
scientific article published in March 2010

    Statements

    Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial (English)
    Frederick J Raal
    Raul D Santos
    A David Marais
    Min-Ji Charng
    Daniel Gaudet
    Ju L Tan
    Scott Chasan-Taber
    Diane L Tribble
    Joann D Flaim
    Stanley T Crooke
    1 March 2010
    998-1006
    9719

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit